IDXX Idexx Laboratories Inc

Price (delayed)

$471.08

Market cap

$39.94B

P/E Ratio

53.11

Dividend/share

N/A

EPS

$8.87

Enterprise value

$40.74B

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and ...

Highlights
The company's equity has surged by 71% YoY
The company's net income has surged by 52% YoY and by 4% QoQ
The quick ratio has decreased by 15% YoY and by 13% QoQ

Key stats

What are the main financial stats of IDXX
Market
Shares outstanding
84.79M
Market cap
$39.94B
Enterprise value
$40.74B
Valuations
Price to earnings (P/E)
53.11
Price to book (P/B)
53.1
Price to sales (P/S)
12.79
EV/EBIT
44.37
EV/EBITDA
39.96
EV/Sales
13
Earnings
Revenue
$3.14B
EBIT
$918.2M
EBITDA
$1.02B
Free cash flow
$662.57M
Per share
EPS
$8.87
Free cash flow per share
$7.78
Book value per share
$8.87
Revenue per share
$36.83
TBVPS
$22.74
Balance sheet
Total assets
$2.39B
Total liabilities
$1.63B
Debt
$942.74M
Equity
$754.75M
Working capital
$304.19M
Liquidity
Debt to equity
1.25
Current ratio
1.48
Quick ratio
0.82
Net debt/EBITDA
0.78
Margins
EBITDA margin
32.5%
Gross margin
58.8%
Net margin
24.1%
Operating margin
29.3%
Efficiency
Return on assets
32.1%
Return on equity
106.7%
Return on invested capital
44.6%
Return on capital employed
52.4%
Return on sales
29.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDXX stock price

How has the Idexx Laboratories stock price performed over time
Intraday
0.98%
1 week
-7.84%
1 month
-28.06%
1 year
1.27%
YTD
-28.46%
QTD
-28.46%

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$3.14B
Gross profit
$1.84B
Operating income
$917.93M
Net income
$756.86M
Gross margin
58.8%
Net margin
24.1%
The company's net income has surged by 52% YoY and by 4% QoQ
IDXX's operating income is up by 47% YoY and by 6% from the previous quarter
The net margin has grown by 26% YoY
The gross profit has increased by 23% YoY and by 2.8% QoQ

Growth

What is Idexx Laboratories's growth rate over time

Valuation

What is Idexx Laboratories stock price valuation
P/E
53.11
P/B
53.1
P/S
12.79
EV/EBIT
44.37
EV/EBITDA
39.96
EV/Sales
13
The company's EPS has surged by 52% YoY and by 4.1% QoQ
IDXX's price to earnings (P/E) is 25% lower than its last 4 quarters average of 69.9 and 10% lower than its 5-year quarterly average of 58.7
The company's equity has surged by 71% YoY
The price to book (P/B) is 22% less than the last 4 quarters average of 67.3
The P/S is 22% below the last 4 quarters average of 16.2 but 21% above the 5-year quarterly average of 10.5
IDXX's revenue is up by 21% year-on-year and by 2.9% since the previous quarter

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has decreased by 46% YoY and by 8% QoQ
Idexx Laboratories's return on invested capital has increased by 40% YoY and by 5% QoQ
The return on assets rose by 24% year-on-year
The company's return on sales rose by 22% YoY and by 3.2% QoQ

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 46% higher than its total liabilities
The company's total assets rose by 17% YoY
The quick ratio has decreased by 15% YoY and by 13% QoQ
The debt is 25% more than the equity
The company's equity has surged by 71% YoY
IDXX's debt to equity is down by 43% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.